Nootropic Peptide Research
Selank and Semax are synthetic peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences that have been investigated in preclinical research for their effects on cognitive pathways, neurotrophic factor expression, and neuromodulatory mechanisms. These peptides represent an emerging area of neuroscience research focused on peptide-mediated cognitive pathway modulation.
Selank: Tuftsin Analog Research
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analog of the immunomodulatory peptide tuftsin with an added Pro-Gly-Pro sequence for metabolic stability. In preclinical models, Selank has been investigated for:
- Effects on brain-derived neurotrophic factor (BDNF) expression in animal models
- Modulation of GABAergic signaling pathways in cellular studies
- Anxiolytic-like behavioral effects in rodent models
- Influence on monoamine neurotransmitter metabolism in brain tissue
Semax: ACTH Analog Research
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analog of the ACTH(4-10) fragment with a stabilizing Pro-Gly-Pro C-terminal extension. Preclinical research areas include:
- Neurotrophic factor expression (BDNF, NGF, GDNF) modulation in cellular and animal models
- Effects on cerebral blood flow and vascular dynamics in animal studies
- Cognitive performance parameters in rodent behavioral models
- Neuroprotective pathway activation in ischemia models
Research Applications
Both peptides serve as valuable research tools for investigators studying cognitive neuroscience, neurotrophic signaling, and neuropeptide pharmacology. Their well-characterized structures and documented preclinical profiles make them useful for mechanistic studies. Explore ROEHN's research catalog for complementary compounds, including BPC-157 and CJC-1295/Ipamorelin.
Research Disclaimer
This article is for educational and informational purposes only. All compounds discussed are intended strictly for in-vitro and preclinical research use. They are not intended for human consumption. Always consult published scientific literature and institutional review protocols before initiating any research program.